Stada’s €5bn LBO to heat up post-summer pipeline

The European leveraged finance markets are licking their lips in anticipation of a new €2.5bn deal backing Bain and Cinven’s takeover of Stada Arzneimittel, the German generic drug manufacturer.

  • By Victor Jimenez
  • 12 Jul 2017

The two private equity firms increased Stada’s takeover valuation by €16m on Monday, raising their new bid from €66 a share to €66.25. Stada’s board backed the raised offer. 

However, the increased offer represents a second bid in just two weeks and will need Germany’s federal financial supervisory authority ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 24 Jul 2017
1 BNP Paribas 11,353.22 62 6.48%
2 Goldman Sachs 10,847.70 40 6.19%
3 JPMorgan 9,883.17 41 5.64%
4 Deutsche Bank 8,939.52 52 5.10%
5 Credit Agricole CIB 8,436.06 46 4.81%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • 25 Jul 2017
1 JPMorgan 5,262.65 41 8.52%
2 Goldman Sachs 4,273.93 33 6.92%
3 Deutsche Bank 4,249.17 39 6.88%
4 Credit Suisse 3,915.70 42 6.34%
5 Barclays 3,740.83 31 6.05%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 25 Jul 2017
1 JPMorgan 22,011.32 165 11.16%
2 Citi 17,958.06 133 9.10%
3 Bank of America Merrill Lynch 15,724.51 136 7.97%
4 Barclays 13,657.72 88 6.92%
5 Goldman Sachs 13,596.26 99 6.89%